Home > Insider Trading > Filing (0001127602-18-012824)

Filing Details

Accession Number:: 0001127602-18-012824
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-27 09:03:15
Reporting Period:: 2018-03-23

Accepted Time:: 2018-03-27 09:03:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
920148	Laboratory Corp Of America Holdings	LH	Services-Medical Laboratories (8071)	133757370

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1275654	P David King	531 South Spring Street Burlington NC 27215	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-03-23	49,967	$84.86	231,202	No	4	M	Direct
Common Stock	Disposition	2018-03-23	1,689	$163.58	229,513	No	4	S	Direct
Common Stock	Disposition	2018-03-23	36,265	$164.55	193,248	No	4	S	Direct
Common Stock	Disposition	2018-03-23	10,313	$165.39	182,935	No	4	S	Direct
Common Stock	Disposition	2018-03-23	1,700	$166.38	181,235	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Options	Disposition	2018-03-23	49,967	$0.00	49,967	$84.86

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
99,933	2013-05-24	2022-05-23	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	27,811	Indirect	By grantor retained annuity trust
Common Stock	47,357	Indirect	By grantor retained annuity trust

Footnotes

Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
The price of $163.5805 per share represents a weighted average of sales prices ranging from $162.96 to $163.865 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $164.5508 per share represents a weighted average of sales prices ranging from $163.995 to $164.98 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $165.3891 per share represents a weighted average of sales prices ranging from $164.99 to $165.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
The price of $166.3752 per share represents a weighted average of sales prices ranging from $166.089 to $166.80 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable.